Catherine Madigan insider trades

Open-market stock purchases and sales by Catherine Madigan, Chief Medical Officer at Hemab Therapeutics Holdings, Inc, from SEC Form 4 filings since Mar 1, 2022.

Recent trades

DateStockTradeValue
Apr 30, 2026COAG Hemab Therapeutics Holdings, IncBought (not open market)—
Jan 29, 2026COAG Hemab Therapeutics Holdings, IncBought (not open market)—

Companies traded

  • COAG Hemab Therapeutics Holdings, Inc: other filings, last Apr 30, 2026
  • SNDX Syndax Pharmaceuticals Inc: other filings, last Feb 2, 2023

Get free alerts when Catherine Madigan files a new trade →